These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 22894751

  • 1. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.
    Li Vecchi V, Soresi M, Giannitrapani L, Mazzola G, La Sala S, Tramuto F, Caruso G, Colomba C, Mansueto P, Madonia S, Montalto G, Di Carlo P.
    BMC Infect Dis; 2012 Aug 15; 12():192. PubMed ID: 22894751
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.
    HIV Med; 2015 Apr 15; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [Abstract] [Full Text] [Related]

  • 3. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Kwak MK, Lee EJ, Park JW, Park SY, Kim B-, Kim TH, Suh K, Koh J-, Lee SH, Byun D-.
    Osteoporos Int; 2019 Jul 15; 30(7):1501-1510. PubMed ID: 30915506
    [Abstract] [Full Text] [Related]

  • 4. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV.
    Vizcarra P, Gallego J, Vivancos MJ, Sifuentes WA, Llop M, Casado JL.
    HIV Res Clin Pract; 2020 Nov 30; 21(2-3):63-71. PubMed ID: 32698706
    [Abstract] [Full Text] [Related]

  • 6. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 Nov 30; 6(20):1-180. PubMed ID: 23074491
    [Abstract] [Full Text] [Related]

  • 7. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.
    Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, Hoffmann ME, Tebas P.
    J Acquir Immune Defic Syndr; 2005 Apr 01; 38(4):426-31. PubMed ID: 15764959
    [Abstract] [Full Text] [Related]

  • 8. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
    Atencio P, Cabello A, Conesa-Buendía FM, Pérez-Tanoira R, Prieto-Pérez L, Carrillo I, Álvarez B, Arboiro-Pinel R, Díaz-Curiel M, Herrero-Beaumont G, Mediero A, Górgolas M.
    BMC Infect Dis; 2021 Jun 09; 21(1):542. PubMed ID: 34107907
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and vitamin D concentration: the challenges in taking care of children and adolescents infected with HIV.
    Carmo FB, Terreri MT, Succi RCM, Beltrão SV, Gouvea AFTB, Paulino ERC, Machado DM.
    Braz J Infect Dis; 2017 Jun 09; 21(3):270-275. PubMed ID: 28399423
    [Abstract] [Full Text] [Related]

  • 10. Milk and yogurt consumption are linked with higher bone mineral density but not with hip fracture: the Framingham Offspring Study.
    Sahni S, Tucker KL, Kiel DP, Quach L, Casey VA, Hannan MT.
    Arch Osteoporos; 2013 Jun 09; 8(0):119. PubMed ID: 23371478
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 09; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 12. A Comparison of Bone Mineral Density and Its Predictors in HIV-Infected and HIV-Uninfected Older Men.
    Nimitphong H, Sungkanuparph S, Saetung S, Chailurkit LO, Sritara C, Musikarat S, Ongphiphadhanakul B.
    Endocr Pract; 2021 Dec 09; 27(12):1225-1231. PubMed ID: 34343711
    [Abstract] [Full Text] [Related]

  • 13. Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women.
    Calmy A, Chevalley T, Delhumeau C, Toutous-Trellu L, Spycher-Elbes R, Ratib O, Zawadynski S, Rizzoli R.
    Osteoporos Int; 2013 Jun 09; 24(6):1843-52. PubMed ID: 23138338
    [Abstract] [Full Text] [Related]

  • 14. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 09; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 15. Low bone mineral density in HIV-positive young Italians and migrants.
    Cascio A, Colomba C, Di Carlo P, Serra N, Lo Re G, Gambino A, Lo Casto A, Guglielmi G, Veronese N, Lagalla R, Sergi C.
    PLoS One; 2020 Mar 09; 15(9):e0237984. PubMed ID: 32881882
    [Abstract] [Full Text] [Related]

  • 16. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J, Stracke H, Bretzel RG.
    J Infect; 2003 May 09; 46(4):221-7. PubMed ID: 12799147
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
    Zeng YQ, Xiao J, Li CL, Wang Y, Zhang L, Pang XL, Wang D, Du J, Zhao HX.
    Chin Med J (Engl); 2020 Dec 03; 133(24):2940-2946. PubMed ID: 33278100
    [Abstract] [Full Text] [Related]

  • 18. Unravelling hip-spine bone mineral density discordance in people living with HIV.
    Vizcarra P, Rosillo M, Del Rey JM, Moreno A, Vivancos MJ, Casado JL.
    J Bone Miner Metab; 2022 Nov 03; 40(6):990-997. PubMed ID: 36038672
    [Abstract] [Full Text] [Related]

  • 19. Effects of dietary intake and life style on bone density in patients with diabetes mellitus type 2.
    de Luis Román DA, Aller R, Perez Castrillon JL, De Luis J, Gonzalez Sagrado M, Izaola O, Romero E, Martín Escudero JC, Herreros V.
    Ann Nutr Metab; 2004 Nov 03; 48(3):141-5. PubMed ID: 15133318
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Nov 03; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.